Feline Infectious Peritonitis Vaccine
Generic: FIP vaccine (intranasal)
The Feline Infectious Peritonitis (FIP) vaccine is an intranasal biological product designed to provide mucosal immunity against feline coronavirus infection, although its clinical efficacy remains a subject of significant debate within the veterinary community.
This medication is intended for cats.
Overview
The FIP vaccine is a modified live-virus biological agent administered intranasally to cats in an effort to stimulate local mucosal immunity against feline coronavirus, the causative agent of Feline Infectious Peritonitis. Unlike the Rabies Vaccine which is a core requirement for feline health, the FIP vaccine is considered a non-core, optional vaccination by the American Association of Feline Practitioners (AAFP). Its historical development sought to mitigate the severe systemic inflammation and vasculitis associated with the mutated form of the feline enteric coronavirus, which transitions into the lethal FIP form within the host. Due to the complex nature of the disease, this vaccine is seldom recommended in modern feline practice, and veterinarians often prioritize other preventative measures like the Chlamydia felis Vaccine for cats in high-risk environments.
The clinical use of the FIP vaccine is highly restricted because studies have historically failed to demonstrate statistically significant protection against the development of clinical FIP in controlled trials. Because the pathogenesis of FIP involves an aberrant immune response to the virus rather than simple viral replication, inducing a standard immune response via vaccination has proven ineffective and, in some cases, potentially counterproductive. It is distinct from other preventative biologics such as the Feline Immunodeficiency Virus Vaccine or the Bordetella Vaccine, which operate under more predictable immunological principles. Clients may encounter this product in specific multi-cat environments or shelters where feline enteric coronavirus is endemic, though its usage has largely declined in favor of improved sanitation and husbandry practices.
Veterinarians must carefully weigh the limited efficacy of the vaccine against the potential risks associated with any biological injection or mucosal application. While the PureVax Rabies (feline) is a standard of care for safety and efficacy, the FIP vaccine does not currently hold a recommendation from the major veterinary advisory boards, including the World Small Animal Veterinary Association (WSAVA). Owners concerned about the health of their cat should discuss comprehensive environmental management strategies instead of relying on this specific vaccination to prevent FIP, as the current consensus among feline specialists emphasizes that the best protection lies in reducing viral shedding and environmental stress.
What It Treats
- Feline Infectious Peritonitis: The primary intent of the vaccine is to stimulate immunity against the feline coronavirus, which is the precursor to FIP.
- Feline Enteric Coronavirus Infection: It targets the broad range of enteric coronavirus strains to prevent or mitigate colonization within the feline digestive tract.
How It Works
The FIP vaccine functions as a temperature-sensitive modified live virus that is delivered through the nasal mucosa. Because the feline coronavirus primarily enters and replicates within the epithelial cells of the gastrointestinal tract, the intranasal administration is intended to stimulate secretory IgA antibodies directly at the site of potential viral entry. By generating a local immune response in the nasal and respiratory passages, the vaccine aims to intercept the virus before it reaches systemic circulation. However, the immune system's interaction with the coronavirus is incredibly complex; the disease FIP is actually an immune-mediated condition where the host's body reacts excessively to the virus, meaning that vaccines may struggle to prevent the condition as they do with standard viral infections.
Dosage
The vaccine is generally administered as a single dose into the nostrils as directed by the manufacturer, typically in kittens starting at 16 weeks of age, followed by a booster if the veterinarian deems it necessary based on high-risk exposure. Always follow the specific instructions provided by your veterinarian as they must determine if the vaccine is appropriate for your individual cat's lifestyle and risk profile.
Administration
The vaccine is administered via the intranasal route. A small volume of the liquid vaccine is applied to the cat's nostrils using an applicator. It is important to ensure the cat receives the full dose and that the administration is performed carefully to prevent sneezing, which could result in the loss of the vaccine volume.
Storage
The vaccine must be stored in a refrigerator at a temperature between 35°F and 45°F (2°C to 7°C). It should be protected from light and never frozen, as freezing can deactivate the live virus and render the product entirely ineffective. Always check the expiration date prior to use and discard any product that has been left at room temperature for an extended period.
Contraindications
The FIP vaccine is strictly contraindicated for cats that are already positive for feline coronavirus, which includes the vast majority of cats residing in multi-cat households or high-density catteries. Because it is a modified live-virus vaccine, it should not be administered to immunocompromised, pregnant, or severely ill cats, as they may not mount an effective immune response or could experience exacerbation of other health conditions. Furthermore, the vaccine is not recommended for cats living in low-risk or single-cat households, as the risk of the disease does not outweigh the potential for side effects or the lack of proven clinical efficacy. Veterinarians will typically conduct a thorough wellness screening to ensure that no underlying pathology is present that could complicate the vaccination process.
Interactions
There are no major documented drug interactions between the FIP vaccine and other routine medications or vaccines, such as the Rabies Vaccine or core respiratory vaccines. However, it is generally recommended to avoid administering multiple modified live-virus vaccines simultaneously if the cat has a known history of vaccine sensitivity or immune-mediated disorders. If the cat is currently on immunosuppressive therapy, such as corticosteroids or chemotherapy, the vaccine should be avoided, as the immune system's ability to create a protective response will be compromised. Always disclose all current medications to your veterinarian before any vaccination protocol is initiated.
Side Effects
- Mild sneezing
- Occasional nasal discharge
- Lethargy or reduced appetite for 24-48 hours
- Injection site reactions (if off-label use occurs)
- Hypersensitivity or anaphylactic reactions (rare but serious)
Sources & References
Frequently Asked Questions
This information is educational only and not a substitute for professional veterinary advice. Always consult a licensed veterinarian before starting or changing any medication.
